Compare STRO & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRO | PANL |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | 133 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.8M | 476.2M |
| IPO Year | N/A | 2015 |
| Metric | STRO | PANL |
|---|---|---|
| Price | $28.58 | $8.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $31.33 | $9.00 |
| AVG Volume (30 Days) | 291.8K | ★ 577.8K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $385,088,209.00 |
| Revenue This Year | N/A | $0.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $39.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $4.27 |
| 52 Week High | $43.85 | $9.39 |
| Indicator | STRO | PANL |
|---|---|---|
| Relative Strength Index (RSI) | 39.92 | 55.32 |
| Support Level | $10.50 | $7.99 |
| Resistance Level | $43.85 | $9.16 |
| Average True Range (ATR) | 3.43 | 0.43 |
| MACD | -1.68 | 0.01 |
| Stochastic Oscillator | 18.56 | 48.21 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Pangaea Logistics Solutions Ltd and its subsidiaries collectively, Pangaea or the Company, provide seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company's operating segments include the shipping segment: The Company's operating segments include the shipping segment and six terminal and stevedoring operating segments. The company operates in the USA, Germany, Canada, Singapore, the United Kingdom, and other countries, with maximum from the USA and others.